中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

肝衰竭合并真菌感染发病特点及预后影响因素

王宇 胡瑾华

引用本文:
Citation:

肝衰竭合并真菌感染发病特点及预后影响因素

DOI: 10.3969/j.issn.1001-5256.2019.02.041
基金项目: 

北京市科委2017年度科技计划重大项目(D171100003117005); 

详细信息
  • 中图分类号: R575.3;R519

Clinical features of patients with liver failure and fungal infections and influencing factors for prognosis

Research funding: 

 

  • 摘要:

    肝衰竭是由多种原因引起的肝功能严重损伤,并发症复杂多样,真菌感染是严重并发症之一,多为肝衰竭晚期表现,严重影响预后,导致病死率显著升高,成为临床工作中面临的棘手问题。介绍了肝衰竭合并真菌感染患者的高危因素、临床特点、诊断方法以及预后影响因素的研究进展,为提高临床诊疗水平提供理论依据,以降低此类患者的病死率,提高其生存质量。

     

  • [1]ROEHMEL JF, TINTELNOT K, BERNHARDT A, et al.Arxula adeninivorans causing invasive pulmonary mycosis and fungaemia in cystic fibrosis[J].Lancet, 2015, 385 (9976) :1476.
    [2]HUANG YB, QIAO Y, CHANG LS, et al.Effect of antiviral therapy on prognosis of patients with decompensated cirrhosis[J].Clin JGastroenterol Hepatol, 2011, 20 (4) :331-334. (in Chinese) 黄玉波, 乔雍, 常路丝, 等.抗病毒治疗对失代偿期乙肝肝硬化患者预后的影响[J].胃肠病学和肝病学杂志, 2011, 20 (4) :331-334.
    [3]XIE GJ, ZHANG HY, CHEN Q, et al.Changing etiologies and outcome of liver failure in Southwest China[J].Virol J, 2016, 13:89.
    [4]ZHENG MH, SHI KQ, FAN YC, et al.A model to determine 3-month mortality risk in patients with acute-on-chronic hepatitis B liver failure[J].Clin Gastroenterol Hepatol, 2011, 9 (4) :351-356.e353.
    [5]WANG XL, SHAO JG, ZHU YC, et al.Epidemiological analysis of acute-on-chronic liver failure in Nantong, Jiangsu Province, 2005-2014[J].Chin J Infect Dis, 2016, 34 (9) :530-535. (in Chinese) 汪徐林, 邵建国, 朱永昌, 等.江苏省南通地区2005年至2014年慢加急性肝功能衰竭流行病学调查分析[J].中华传染病杂志, 2016, 34 (9) :530-535.
    [6]PHILIPS CA, SARIN SK.Sepsis in cirrhosis:Emerging concepts in pathogenesis, diagnosis and management[J].Hepatol Int, 2016, 10 (6) :871-882.
    [7]HU SY, CHEN YW, PAN ZQ, et al.Risk factors of liver failure-related hospital infection in China:A meta-analysis[J].JZunyi Med Univ, 2014, 37 (5) :520-528. (in Chinese) 胡世芸, 陈妍雯, 潘宗琴, 等.我国肝衰竭医院感染危险因素的Meta分析[J].遵义医学院学报, 2014, 37 (5) :520-528.
    [8]SCHMIEDEL Y, ZIMMERLI S.Common invasive fungal diseases:An overview of invasive candidiasis, aspergillosis, cryptococcosis, and pneumocystis pneumonia[J].Swiss Med Wkly, 2016, 146:w14281.
    [9]MATSUBARA VH, BANDARA HM, MAYER MP, et al.Probiotics as antifungals in mucosal candidiasis[J].Clin Infect Dis, 2016, 62 (9) :1143-1153.
    [10]Society of Infectious Diseases, Chinese Medical Association.Expert consensus on diagnosis and treatment of end-stage liver disease complicated infections[J].J Clin Hepatol, 2018, 34 (9) :1862-1872. (in Chinese) 中华医学会感染病学分会.终末期肝病合并感染诊治专家共识[J].临床肝胆病杂志, 2018, 34 (9) :1862-1872.
    [11]LING Z, LIU X, CHENG Y, et al.Blood microbiota as a potential noninvasive diagnostic biomarker for liver fibrosis in severely obese patients:Choose carefully[J].Hepatology, 2017, 65 (5) :1775-1776.
    [12]FIORE M, LEONE S.Spontaneous fungal peritonitis:Epidemiology, current evidence and future prospective[J].World JGastroenterol, 2016, 22 (34) :7742-7747.
    [13]GRAVITO-SOARES M, GRAVITO-SOARES E, LOPES S, et al.Spontaneous fungal peritonitis:A rare but severe complication of liver cirrhosis[J].Eur J Gastroenterol Hepatol, 2017, 29 (9) :1010-1016.
    [14]HWANG SY, YU SJ, LEE JH, et al.Spontaneous fungal peritonitis:A severe complication in patients with advanced liver cirrhosis[J].Eur J Clin Microbiol Infect Dis, 2014, 33 (2) :259-264.
    [15]HASSAN EA, ABD EL-REHIM AS, HASSANY SM, et al.Fungal infection in patients with end-stage liver disease:Low frequency or low index of suspicion[J].Int J Infect Dis, 2014, 23:69-74.
    [16]LAHMER T, BRANDL A, RASCH S, et al.Fungal peritonitis:Underestimated disease in critically ill patients with liver cirrhosis and spontaneous peritonitis[J].PLo S One, 2016, 11 (7) :e0158389.
    [17]WANG L, LIU SZ, WANG SY, et al.Effect of broad-spectrum antibiotics on invasive fungal infection induced by intestinal flora disturbance[J].J Trauma Surg, 2010, 12 (4) :306-309. (in Chinese) 王虑, 刘绍泽, 王胜云, 等.广谱抗生素对肠道菌群紊乱诱导的侵袭性真菌感染的影响[J].创伤外科杂志, 2010, 12 (4) :306-309.
    [18]SINGH JA, CAMERON C, NOORBALOOCHI S, et al.Risk of serious infection in biological treatment of patients with rheumatoid arthritis:A systematic review and meta-analysis[J].Lancet, 2015, 386 (9990) :258-265.
    [19]JACOBS JW, BIJLSMA JW, van LAAR JM.Glucocorticoids in early rheumatoid arthritis:Are the benefits of joint-sparing effects offset by the adverse effect of osteoporosis?the effects on bone in the utrecht study and the CAMERA-II study[J].Neuroimmunomodulation, 2015, 22 (1-2) :66-71.
    [20]HAO F, WANG L, ZHOU CJ.Glucocorticoids and invasive fungal infections:A review[J].Chin J Mycol, 2012, 7 (6) :367-371. (in Chinese) 郝飞, 王莉, 周村建.糖皮质激素与侵袭性真菌感染[J].中国真菌学杂志, 2012, 7 (6) :367-371.
    [21]GUSTOT T, MAILLART E, BOCCI M, et al.Invasive aspergillosis in patients with severe alcoholic hepatitis[J].J Hepatol, 2014, 60 (2) :267-274.
    [22]CHEN YW, HU SY, PAN ZQ, et al.Meta-analysis of risk factors for fungal infections in liver failure patients in China[J].Chin JNosocomiol, 2014, 24 (10) :2493-2496. (in Chinese) 陈妍雯, 胡世芸, 潘宗琴, 等.我国肝衰竭真菌感染危险因素荟萃分析[J].中华医院感染学杂志, 2014, 24 (10) :2493-2496.
    [23]ZHANG ZC, ZHANG J, TAN RX, et al.A clinical analysis of liver failure with fungal infection[J].Jiangxi Med J, 2011, 46 (3) :247-249. (in Chinese) 张志成, 张骏, 谭荣欣, 等.肝衰竭合并真菌感染临床分析[J].江西医药, 2011, 46 (3) :247-249.
    [24]LIN YY, SHIAU S, FANG CT.Risk factors for invasive Cryptococcus neoformans diseases:A case-control study[J].PLo S One, 2015, 10 (3) :e0119090.
    [25]KIM BS, LEE SG, HWANG S, et al.Influence of pretransplantation bacterial and fungal culture positivity on outcome after living donor liver transplantation[J].Transplant Proc, 2009, 41 (1) :250-252.
    [26]WANG ZW, MENG CP, SHEN HJ, et al.Pathogenic characteristics and related factors of nosocomial infections in patients with severe hepatitis[J].Chin J Nosocomiol, 2018, 28 (4) :535-537, 542. (in Chinese) 王志炜, 孟春萍, 沈华江, 等.重型肝炎患者医院感染病原学特点及相关因素分析[J].中华医院感染学杂志, 2018, 28 (4) :535-537, 542.
    [27]LIN LN, ZHU Y, CHE FB, et al.Invasive fungal infections secondary to acute-on-chronic liver failure:A retrospective study[J].Mycoses, 2013, 56 (4) :429-433.
    [28]SU HB, WANG HF, LI C, et al.Liver failure complicated by multi-system invasive fungal infections[J].Infect Dis Info, 2010, 23 (2) :95-97. (in Chinese) 苏海滨, 王慧芬, 李晨, 等.肝衰竭并发多系统侵袭性真菌感染临床分析[J].传染病信息, 2010, 23 (2) :95-97.
    [29]BENNETT JE.Echinocandins for candidemia in adults without neutropenia[J].N Engl J Med, 2006, 355 (11) :1154-1159.
    [30] Chinese Invasive Fungal Infection Working Group.The Chinese guidelines for the diagnosis and treatment of invasive fungal disease in patients with hematological disorders and cancers (the fifth revision) [J].Chin J Intern Med, 2017, 56 (6) :453-459. (in Chinese) 中国侵袭性真菌感染工作组.血液病/恶性肿瘤患者侵袭性真菌病的诊断标准与治疗原则 (第五次修订版) [J].中华内科杂志, 2017, 56 (6) :453-459.
    [31]ZHANG L, LIU ZY.End-stage liver disease and invasive fungal infection[J].Chin J Hepatol, 2018, 26 (1) :13-16. (in Chinese) 张黎, 刘正印.终末期肝病与侵袭性真菌感染[J].中华肝脏病杂志, 2018, 26 (1) :13-16.
    [32]CHOUDHURY A, KUMAR M, SHARMA BC, et al.Systemic inflammatory response syndrome in acute-on-chronic liver failure:Relevance of'golden window':A prospective study[J].J Gastroenterol Hepatol, 2017, 32 (12) :1989-1997.
    [33]SARIN SK, CHOUDHURY A.Acute-on-chronic liver failure[J].Curr Gastroenterol Rep, 2016, 18 (12) :61.
    [34]LIN CC, WANG CC, HUNG KC, et al.Study of porcine hepatocyte-entrapped bioartificial liver in surgery-induced fulminant hepatic failure rabbits[J].Biochem Eng J, 2013, 76 (6) :55-59.
    [35]KIM TS, JOH JW, MOON H, et al.The different etiology of fulminant hepatic failure (FHF) in Korea and prognostic factors in patients undergoing liver transplantation for FHF[J].Clin Transplant, 2013, 27 (2) :297-302.
    [36]HU SY, CHEN YW, PAN ZQ, et al.Prognosis of liver failure related hospital infection in China:A Meta-analysis[J].World Chin J Dig, 2014, 22 (21) :3133.
    [37]GU AB, GONG HY, HUANG MM, et al.Clinical features and prognostic factors of elderly patients with liver failure complicated with fungal infection[J].Chin J Curr Adv Gen Surg, 2017, 20 (5) :358-361. (in Chinese) 郭爱斌, 龚海燕, 黄明敏, 等.肝功能衰竭合并真菌感染老年患者的临床特点及预后影响因素[J].中国现代普通外科进展, 2017, 20 (5) :358-361.
    [38]ZHAO JM, ZHAO PL, ZHANG L, et al.Relationship between major complications and prognosis of 96 patients with liver failure[J/CD].Chin J Liver Dis:Electr Version, 2018, 10 (3) :77-81. (in Chinese) 赵俊梅, 赵培利, 张璐, 等.96例肝功能衰竭患者主要并发症与预后的相关性[J/CD].中国肝脏病杂志:电子版, 2018, 10 (3) :77-81.
    [39]YAN T, WANG HF, SU HB, et al.Clinical study of factors in predicting prognosis of patients with hepatic failure after invasive fungal infections[J].J Clin Hepatol, 2009, 25 (2) :110-113. (in Chinese) 闫涛, 王慧芬, 苏海滨, 等.肝衰竭患者合并侵袭性真菌感染后患者转归的影响因素分析[J].临床肝胆病杂志, 2009, 25 (2) :110-113.
    [40]USHIJIMA Y, TAJIMA T, YOSHIMITSU K, et al.Radiological catheter placement for transcatheter arterial steroid injection therapy to treat severe acute hepatic failure:Technical feasibility and efficacy[J].Acta Radiol, 2012, 53 (2) :140-146.
    [41]LIN F, WANG HF, SU HB, et al.Impacts of different fungous infections on severity and prognosis of patients with liver failure[J].J Pract Hepatol, 2009, 12 (1) :35-37. (in Chinese) 林芳, 王慧芬, 苏海滨, 等.不同真菌感染对肝衰竭患者病情及预后的影响[J].实用肝脏病杂志, 2009, 12 (1) :35-37.
    [42]LU H, LI MY, TAN KP, et al.Influence of different fungal infections on the condition and prognosis of patients with liver failure[J].Chin Hepatol, 2017, 22 (4) :332-334. (in Chinese) 陆晖, 李孟英, 谭可平, 等.不同真菌感染对肝衰竭患者病情及预后影响的研究[J].肝脏, 2017, 22 (4) :332-334.
    [43]ZHANG DJ, ZHOU B, HOU JL.Research progress in prognostic models of acute-on-chronic liver failure[J].J Clin Hepatol, 2018, 34 (6) :1351-1356. (in Chinese) 张东敬, 周彬, 侯金林.慢加急性肝衰竭预后模型的研究进展[J].临床肝胆病杂志, 2018, 34 (6) :1351-1356.
    [44]WU D, SUN Z, LIU X, et al.HINT:A novel prognostic model for patients with hepatitis B virus-related acute-on-chronic liver failure[J].Aliment Pharmacol Ther, 2018, 48 (7) :750-760.
    [45]ZHANG H, JIA L, YAO SW, et al.Value of MELD combined with serum sodium concentration in predicting the short-term outcome of patients with HBV-related acute-on-chronic liver failure in China:A Meta-analysis[J].J Clin Hepatol, 2018, 34 (9) :1950-1955. (in Chinese) 张辉, 贾雷, 姚士伟, 等.MELD-Na评分对我国HBV相关慢加急性肝衰竭短期预后预测价值的Meta分析[J].临床肝胆病杂志, 2018, 34 (9) :1950-1955.
    [46]GRONBAEK H, RODGAARD-HANSEN S, AAGAARD NK, et al.Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF) [J].J Hepatol, 2016, 64 (4) :813-822.
    [47]FISCHER J, SILVA TE, SOARES ESPE, et al.From stable disease to acute-on-chronic liver failure:Circulating cytokines are related to prognosis in different stages of cirrhosis[J].Cytokine, 2017, 91:162-169.
    [48]BERNAL W, JALAN R, QUAGLIA A, et al.Acute-on-chronic liver failure[J].Lancet, 2015, 386 (10003) :1576-1587.
    [49]PAPPAS PG, KAUFFMAN CA, ANDES DR, et al.Clinical practice guideline for the management of candidiasis:2016 update by the Infectious Diseases Society of America[J].Clin Infect Dis, 2016, 62 (4) :e1-e50.
    [50]HUANG Y, LI Z, LEI Y, et al.Diagnosis and treatment of invasive fungal infection in 102 patients with end-stage liver disease[J].J Chongqing Med Univ, 2017, 42 (7) :808-812. (in Chinese) 黄祎, 李哲, 雷宇, 等.102例终末期肝病患者并发侵袭性真菌感染的诊断、治疗研究[J].重庆医科大学学报, 2017, 42 (7) :808-812.
    [51]CHEN J, YANG Q, HUANG J, et al.Risk factors for invasive pulmonary aspergillosis and hospital mortality in acute-onchronic liver failure patients:A retrospective-cohort study[J].Int J Med Sci, 2013, 10 (12) :1625-1631.
  • 加载中
计量
  • 文章访问数:  1460
  • HTML全文浏览量:  16
  • PDF下载量:  389
  • 被引次数: 0
出版历程
  • 收稿日期:  2018-09-11
  • 出版日期:  2019-02-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回